Benefits persist for lenvatinib plus pembrolizumab in advanced kidney cancer
Lenvatinib plus pembrolizumab has already been shown to improve survival [...]
Lenvatinib plus pembrolizumab has already been shown to improve survival [...]
At the American Society of Clinical Oncology Genitourinary Cancers Symposium [...]
At the American Society of Clinical Oncology Genitourinary Cancers Symposium [...]
Non-clear cell kidney cancer is a group of different subtypes [...]
The National Institute for Health and Care Excellence (NICE) has [...]
When ipilimumab plus nivolumab or axitinib plus pembrolizumab are used [...]
Yesterday is was announced that the Scottish Medicines Consortium (SMC) [...]
Late last week we learnt that the National Institute for [...]
The phase 2 KEYNOTE-B61 study was presented at the recent [...]
Results from the phase 3 CLEAR studywere presented at the [...]